AR and prostate carcinoma: Members of the canonical Wnt pathway, including Wnt-3a and Wnt-1 and β-catenin, have been shown to be up-regulated in metastatic prostate cancer and β-catenin and AR have been shown to co-localize in the nucleus in advanced prostate cancer samples.